BARCLAYS PLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,094
-37.1%
23,793
-21.4%
0.00%0.0%
Q2 2023$1,738
+12.3%
30,257
-26.8%
0.00%0.0%
Q1 2023$1,548
-12.2%
41,314
-34.3%
0.00%0.0%
Q4 2022$1,764
-99.9%
62,930
+13.4%
0.00%
-50.0%
Q3 2022$1,559,000
-30.2%
55,504
-13.4%
0.00%
+100.0%
Q2 2022$2,232,000
+18.8%
64,118
+22.5%
0.00%0.0%
Q1 2022$1,879,000
-45.1%
52,345
-64.4%
0.00%0.0%
Q4 2021$3,420,000
+182.2%
146,860
+130.1%
0.00%0.0%
Q3 2021$1,212,000
+31.6%
63,817
+39.7%
0.00%
Q2 2021$921,000
-33.1%
45,686
-39.2%
0.00%
-100.0%
Q1 2021$1,377,000
-6.1%
75,117
+3.1%
0.00%0.0%
Q4 2020$1,467,000
+13.7%
72,888
+6.0%
0.00%0.0%
Q3 2020$1,290,000
+2.5%
68,779
+22.7%
0.00%0.0%
Q2 2020$1,258,000
+96.0%
56,068
+29.6%
0.00%0.0%
Q1 2020$642,000
-39.4%
43,275
-21.3%
0.00%0.0%
Q4 2019$1,060,000
+42.9%
54,961
+47.0%
0.00%
Q3 2019$742,000
-15.0%
37,397
-9.7%
0.00%
-100.0%
Q2 2019$873,000
+37.7%
41,401
+33.3%
0.00%
Q1 2019$634,000
+139.2%
31,049
+133.2%
0.00%
Q4 2018$265,000
-63.8%
13,316
-65.1%
0.00%
-100.0%
Q3 2018$733,000
+163.7%
38,112
+108.4%
0.00%
Q2 2018$278,000
-15.2%
18,289
+4.3%
0.00%
Q1 2018$328,000
+192.9%
17,530
+203.1%
0.00%
Q4 2017$112,000
+646.7%
5,784
+586.9%
0.00%
Q3 2017$15,000
-85.7%
842
-85.7%
0.00%
Q2 2017$105,000
+78.0%
5,868
+46.8%
0.00%
Q1 2017$59,000
-96.3%
3,997
-95.4%
0.00%
-100.0%
Q4 2016$1,615,000
+112.5%
87,692
+118.7%
0.00%
+100.0%
Q3 2016$760,000
+708.5%
40,102
+585.2%
0.00%
Q2 2016$94,000
+184.8%
5,853
+116.2%
0.00%
Q1 2016$33,000
+266.7%
2,707
+281.3%
0.00%
Q4 2015$9,000
-94.2%
710
-95.0%
0.00%
Q3 2015$156,000
+1200.0%
14,152
+1921.7%
0.00%
Q2 2015$12,000
+9.1%
700
-10.7%
0.00%
Q1 2015$11,000
+37.5%
784
+8.0%
0.00%
Q4 2014$8,0007260.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders